2022年12月最新中科院JCR期刊分区表数据（升级版）已经更新，欢迎查询！ 如果您对期刊系统有任何需求或者问题，欢迎反馈给我们。
 |
| 基本信息 | 登录收藏 | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名字 | JOURNAL OF CONTROLLED RELEASE J CONTROL RELEASE LetPub评分 9.2
60人评分
我要评分
声誉 9.9 影响力 8.6 速度 8.9 | |||||||||||||||||
| 期刊ISSN | 0168-3659 | 微信扫码收藏此期刊 | ||||||||||||||||
| E-ISSN | 1873-4995 | |||||||||||||||||
| 2021-2022最新影响因子 （数据来源于搜索引擎） | 注册或登录后，查看影响因子和历年趋势图 | |||||||||||||||||
| 2021-2022自引率 | 6.30%注册或登录后，查看自引率趋势图 | |||||||||||||||||
| h-index | 237 | |||||||||||||||||
| CiteScore |
| |||||||||||||||||
| 期刊简介 | The Journal of Controlled Release (JCR) publishes high-quality research articles in the broad field of delivery science and technology. This includes drug delivery systems and all aspects of formulations, such as physicochemical and biological properties of drugs, design and characterization of dosage forms, release mechanisms, in vivo testing, and formulation research and development in the disciplines of pharmaceutical, diagnostic, agricultural, environmental, cosmetic, and food industries. Manuscripts that advance fundamental understanding of principles and/or demonstrate advantages of novel technologies in safety and efficacy over current clinical standards will be given priority. Each issue has the cover story highlighting the significance of a selected article published in the issue. At the end of each quarter, the JCR editors select "The Editors' Choice" from the published research articles. | |||||||||||||||||
| 期刊官方网站 | http://www.elsevier.com/wps/find/journaldescription.cws_home/502690/description#description | |||||||||||||||||
| 期刊投稿网址 | https://www.editorialmanager.com/COREL | |||||||||||||||||
| 是否OA开放访问 | No | |||||||||||||||||
| 通讯方式 | ELSEVIER SCIENCE BV, PO BOX 211, AMSTERDAM, NETHERLANDS, 1000 AE | |||||||||||||||||
| 出版商 | Elsevier | |||||||||||||||||
| 涉及的研究方向 | 医学-化学综合 | |||||||||||||||||
| 出版国家或地区 | NETHERLANDS | |||||||||||||||||
| 出版语言 | English | |||||||||||||||||
| 出版周期 | Semimonthly | |||||||||||||||||
| 出版年份 | 1984 | |||||||||||||||||
| 年文章数 | 676注册或登录后，查看年文章数趋势图 | |||||||||||||||||
| Gold OA文章占比 | 9.83% | |||||||||||||||||
| 研究类文章占比： 文章 ÷（文章 + 综述） | 74.85% | |||||||||||||||||
| WOS期刊SCI分区 （ 2021-2022年最新版） | WOS分区等级：1区
| |||||||||||||||||
| 中科院《国际期刊预警 名单（试行）》名单 | 2021年12月发布的2021版：不在预警名单中 2021年01月发布的2020版：不在预警名单中 | |||||||||||||||||
| 中科院SCI期刊分区 （ 2022年12月最新升级版） | 注册或登录后，查看中科院SCI期刊分区趋势图
| |||||||||||||||||
| 中科院SCI期刊分区 （ 2021年12月基础版） |
| |||||||||||||||||
| 中科院SCI期刊分区 （ 2021年12月升级版） |
| |||||||||||||||||
| 中科院SCI期刊分区 （ 2020年12月旧的升级版） |
| |||||||||||||||||
| SCI期刊收录coverage | Science Citation Index Expanded (SCIE) (2020年1月，原SCI撤销合并入SCIE，统称SCIE) Scopus (CiteScore) | |||||||||||||||||
| PubMed Central (PMC)链接 | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=0168-3659%5BISSN%5D | |||||||||||||||||
| 平均审稿速度 | 网友分享经验： 平均2.6个月 来源Elsevier官网： 平均6.2周 | |||||||||||||||||
| 平均录用比例 | 网友分享经验： 50% | |||||||||||||||||
| 在线出版周期 | 来源Elsevier官网： 平均6.2周 | |||||||||||||||||
| 期刊常用信息链接 |
| |||||||||||||||||
|
|
| |
| 注册或登录后，查看自引率趋势图 |
| 注册或登录后，查看中科院SCI期刊分区趋势图 |
| 注册或登录后，查看年文章数趋势图 |
| 中国学者近期发表的论文 | |
| 1. | Modulation of pericytes by a fusion protein comprising of a PDGFRβ-antagonistic affibody and TNFα induces tumor vessel normalization and improves chemotherapy Author: Qing Fan, Ze Tao, Hao Yang, Qiuxiao Shi, Hong Wang, Dianlong Jia, Lin Wan, Jie Zhang, Jingqiu Cheng, Xiaofeng Lu Journal: JOURNAL OF CONTROLLED RELEASE, 2019, Vol., , DOI:10.1016/j.jconrel.2019.03.018 DOI |
| 2. | Thermosensitive nanocomposite gel for intra-tumoral two-photon photodynamic therapy Author: Lei Luo, Qi Zhang, Yonghuang Luo, Zhonggui He, Xiaohe Tian, Giuseppe Battaglia Journal: JOURNAL OF CONTROLLED RELEASE, 2019, Vol.298, 99-109, DOI:10.1016/j.jconrel.2019.01.019 DOI |
| 3. | Adhesive nanoparticles with inflammation regulation for promoting skin flap regeneration Author: Xiyuan Mao, Lili Liu, Liying Cheng, Ruoyu Cheng, Lu Zhang, Lianfu Deng, Xiaoming Sun, Yuguang Zhang, Bruno Sarmento, Wenguo Cui Journal: JOURNAL OF CONTROLLED RELEASE, 2019, Vol.297, 91-101, DOI:10.1016/j.jconrel.2019.01.031 DOI |
| 4. | Photothermal cancer immunotherapy by erythrocyte membrane-coated black phosphorus formulation Author: Xin Liang, Xinyu Ye, Chao Wang, Chenyang Xing, Qianwei Miao, Zhongjian Xie, Xiuli Chen, Xudong Zhang, Han Zhang, Lin Mei Journal: JOURNAL OF CONTROLLED RELEASE, 2019, Vol.296, 150-161, DOI:10.1016/j.jconrel.2019.01.027 DOI |
| 5. | Injectable thermosensitive hydrogel systems based on functional PEG/PCL block polymer for local drug delivery Author: Hongzhang Deng, Anjie Dong, Jibin Song, Xiaoyuan Chen Journal: JOURNAL OF CONTROLLED RELEASE, 2019, Vol.297, 60-70, DOI:10.1016/j.jconrel.2019.01.026 DOI |
| 6. | Redox/pH dual-stimuli responsive camptothecin prodrug nanogels for “on-demand” drug delivery Author: Ying Qu, Bingyang Chu, XiaWei Wei, Minyi Lei, Danrong Hu, Ruoyu Zha, Lin Zhong, Mengyao Wang, Fangfang Wang, Zhiyong Qian Journal: JOURNAL OF CONTROLLED RELEASE, 2019, Vol., , DOI:10.1016/j.jconrel.2019.01.016 DOI |
| 7. | KRAS-enhanced macropinocytosis and reduced FcRn-mediated recycling sensitize pancreatic cancer to albumin-conjugated drugs Author: Huiqin Liu, Mengnan Sun, Zhengsheng Liu, Chao Kong, Weijian Kong, Junxiao Ye, Jianan Gong, David C.S. Huang, Feng Qian Journal: JOURNAL OF CONTROLLED RELEASE, 2019, Vol.296, 40-53, DOI:10.1016/j.jconrel.2019.01.014 DOI |
| 8. | Reassembly of native components with donepezil to execute dual-missions in Alzheimer's disease therapy Author: Huaqing Zhang, Yuanpei Zhao, Miao Yu, Ziqiang Zhao, Peixin Liu, Hao Cheng, Yi Ji, Yi Jin, Bo Sun, Jianping Zhou, Yang Ding Journal: JOURNAL OF CONTROLLED RELEASE, 2019, Vol.296, 14-28, DOI:10.1016/j.jconrel.2019.01.008 DOI |
| 9. | Pulmonary delivery by exploiting doxorubicin and cisplatin co-loaded nanoparticles for metastatic lung cancer therapy Author: Caina Xu, Yanbing Wang, Zhaopei Guo, Jie Chen, Lin Lin, Jiayan Wu, Huayu Tian, Xuesi Chen Journal: JOURNAL OF CONTROLLED RELEASE, 2018, Vol.295, 153-163, DOI:10.1016/j.jconrel.2018.12.013 DOI |
| 10. | Anti-tumour activity of low molecular weight heparin doxorubicin nanoparticles for histone H1 high-expressive prostate cancer PC-3M cells Author: Shuang Zhang, Zhan-Tao Li, Man Liu, Jing-Ru Wang, Mei-Qi Xu, Zhuo-Yue Li, Xiao-Chuan Duan, Yan-Li Hao, Xiu-Chai Zheng, Hui Li, Zhen-Han Feng, Xuan Zhang Journal: JOURNAL OF CONTROLLED RELEASE, 2018, Vol.295, 102-117, DOI:10.1016/j.jconrel.2018.12.034 DOI |
|
|
  | |
|
以上SCI期刊相关数据和信息来源于网络，仅供参考。
投稿状态统计： 我要评分： | |
同领域作者分享投稿经验：共30条 （包含回复） |
我来分享 |
|
|
联系我们 | 站点地图 | 友情链接 | 授权代理商 | 加入我们
© 2010-2023 中国: LetPub上海分公司 网站备案号：沪ICP备10217908号-1 
沪公网安备号：31010402006960
增值电信业务经营许可证：沪B2-20211595
礼翰商务信息咨询（上海）有限公司 办公地址：上海市徐汇区漕溪北路88号圣爱大厦2103室
United States: Tel: 1-781-202-9968 Address: 400 5th Ave, Suite 530, Waltham, Massachusetts 02451
安全保密
